Diabetes Mellitus, Type 2Diabetes Mellitus, Type 1Sulfonylurea CompoundsHypoglycemic AgentsDiabetes MellitusBlood GlucoseDiabetic NeuropathiesHemoglobin A, GlycosylatedGlipizideInsulinDiabetic NephropathiesGlyburideTolbutamideDiabetes ComplicationsCase-Control StudiesObesityRisk FactorsSulfonylurea ReceptorsDiabetes Mellitus, ExperimentalPotassium Channels, Inwardly RectifyingMetforminTolazamideReceptors, DrugMunchausen SyndromeDiabetes, GestationalGliclazideIslets of LangerhansPotassium ChannelsHypoglycemiaHyperglycemiaDipeptidyl-Peptidase IV InhibitorsThiazolidinedionesATP-Binding Cassette TransportersChlorpropamideCyclohexanesInsulin-Secreting CellsKATP ChannelsGlucose Tolerance TestDiabetic AngiopathiesGlucoseAcetolactate SynthaseVenomsInsulin ResistanceIncretinsInsulinomaGlucagon-Like Peptide 1Diabetic RetinopathyTreatment OutcomeCohort StudiesRetrospective StudiesPrevalenceDiazoxidePregnancy in DiabeticsStreptozocinDiabetic KetoacidosisAdenosine TriphosphateDrug Therapy, CombinationBody Mass IndexAdenoma, Islet CellHypertensionPrediabetic StateCarbamatesGlucose IntoleranceProspective StudiesFollow-Up StudiesCardiovascular DiseasesDiabetes InsipidusIncidenceBlood Glucose Self-MonitoringTime FactorsC-PeptideAlbuminuriaFastingBiological MarkersGlutamate DecarboxylaseCross-Sectional StudiesRisk AssessmentDiabetic DietComorbidityAge FactorsPregnancyDose-Response Relationship, DrugMice, Inbred NODBlood PressurePotassium Channel BlockersMetabolic Syndrome XAdministration, OralMultivariate AnalysisRats, Inbred BBMyocardial InfarctionAlloxanUnited StatesPhenylalanineSex FactorsReference ValuesInsulin Infusion SystemsBody WeightFructosamineLogistic ModelsLipids